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Abstract
In the dorsal raphe nucleus (DR), extracellular serotonin
(5-HT) regulates serotonergic transmission through 5-HT1A
autoreceptors. In this work we used in vivo microdialysis to
examine the effects of stressful and pharmacological chal-
lenges on DR 5-HT efflux in 5-HT1A receptor knockout
(5-HT1A–/–) mice and their wild-type counterparts (5-HT1A+/+).
Baseline 5-HT concentrations did not differ between both lines
of mice, which is consistent with a lack of tonic control of
5-HT1A autoreceptors on DR 5-HT release. (R)-(+)-8-Hydroxy-
2-(di-n-propylamino)tetralin hydrobromide (8-OH-DPAT,
0.5 mg/kg) reduced 5-HT levels to 30% of basal values in
5-HT1A+/+ mice, but not in 5-HT1A–/– mice. The selective
5-HT1B receptor agonist 1,4-dihydro-3-(1,2,3,6-tetrahydro-4-
pyridinyl)-5H-pyrrolo[3,2-b]pyridin-5-one dihydrochloride (CP
93129, 300 lM) reduced dialysate 5-HT to the same extent
(30–40% of baseline) in the two genotypes, which suggests
a lack of compensatory changes in 5-HT1B receptors in the
DR of such mutant mice. Both a saline injection and handling
for 3 min increased DR dialysate 5-HT in mutants, but not in
5-HT1A+/+ mice. Fluoxetine (5 and 20 mg/kg) elevated 5-HT
in a dose-dependent manner in both genotypes. However,
this effect was markedly more pronounced in the 5-HT1A–/–
mice. The increased responsiveness of the extracellular
5-HT in the DR of 5-HT1A receptor knockout mice reflects
a lack of the autoinhibitory control exerted by 5-HT1A
autoreceptors.
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The serotonin (5-hydroxytryptamine [5-HT]) system partici-
pates in many physiological functions (Jacobs and Azmitia
1992) and is involved in several psychiatric disorders (Calde-
cott-Hazard et al. 1991; Mann 1999). The multiple functions
of the transmitter have been attributed to its action on 14
different subtypes of 5-HT receptors recognized so far (Barnes
and Sharp 1999). Among them, 5-HT1A receptors play a
crucial role in regulating the activity of 5-HT neurons. In the
mammalian brain, the principal source of the serotonergic
innervation of the forebrain is the dorsal raphe nucleus (DR)
located in the midbrain (Azmitia and Segal 1978; Imai et al.
1986; Jacobs and Azmitia 1992). Within the DR, 5-HT1A
receptors act as autoreceptors controlling 5-HT cell ﬁring
(Sprouse and Aghajanian 1986; VanderMaelen et al. 1986;
Sinton and Fallon 1988) and release (Hutson et al. 1989; Sharp
et al. 1989; Bonvento et al. 1992; Adell et al. 1993; Kreiss
and Lucki 1994). However, 5-HT1A autoreceptors do not
appear to be tonically activated by the endogenous transmitter
(Adell et al. 2002; Johnson et al. 2002). Therefore, it could be
expected thatmice lacking this receptor, although being devoid
of such an autoinhibitory control, would exhibit an unchanged
basal 5-HT efﬂux. In line with this hypothesis, it has been
observed that the spontaneous ﬁring rate of DR serotonergic
neurons in 5-HT1A receptor knockoutmice is in the same range
as their wild-type counterparts (Richer et al. 2002; Adell et al.
2003), although in a subpopulation of such neurons the
discharge rate nearly doubled (Richer et al. 2002). In addition,
the genetic disruption of 5-HT1A receptors does not appear to
alter either the in vivo efﬂux of 5-HT in forebrain regions
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(He et al. 2001; Knobelman et al. 2001b; Adell et al. 2003) or
the in vitro release of [3H]5-HT from slices of the forebrain or
the midbrain containing the raphe nuclei (Ramboz et al. 1998;
Richer et al. 2002). Nevertheless, a recent study reported
increased dialysate 5-HT in the frontal cortex and hippocam-
pus of 8–10-month-old 5-HT1A receptor knockout mice
(Parsons et al. 2001). It is possible that age and/or genetic
background, as well as environmental conditions are respon-
sible for these discrepancies. In contrast to the above
hypothesis, an increased total tissue content of the 5-HT
metabolite 5-hydroxyindoleacetic acid has been found in
several brain regions of 5-HT1A receptor knockout mice,
including the DR (Ase et al. 2000). However, this ﬁnding is
not consistent with that of Ramboz et al. (1998), although both
studies agree in that the concentration of 5-HT throughout the
brain is not altered in mice lacking 5-HT1A receptors.
The presence of 5-HT in the extracellular space within the
raphe nuclei can regulate the release of the transmitter
throughout the brain by means of the activation of somato-
dendritic 5-HT1A receptors (for review, see Adell et al.
2002). However, in spite of the importance of extracellular 5-
HT in the raphe nuclei, to our knowledge no study has been
conducted in vivo to determine possible differences in the
efﬂux of 5-HT in the DR of 5-HT1A receptor knockout mice.
For this reason, in the present work, we have examined the
effects of stress and the selective serotonin reuptake inhibitor
(SSRI) ﬂuoxetine on the in vivo efﬂux of 5-HT in the DR of
mutant mice and their wild-type counterparts. In addition, the
responsiveness of local 5-HT1B receptors was also studied to
determine whether adaptive changes might have developed
as a consequence of the constitutive inactivation of the gene
coding for the 5-HT1A receptor.
Materials and methods
Animals
Male homozygous 5-HT1A receptor knockout (5-HT1A–/–) and
wild-type (5-HT1A+/+) mice had the same genetic background, i.e.
C57BL/6, and were 10–12 weeks old. 5-HT1A receptor knockout
mice were generated at Princeton University by homologous
recombination, as previously described (Parks et al. 1998). From
this initial source some individuals were transferred in order to grow
a stable colony in the animal facility of the University of Barcelona
School of Medicine. The animals were maintained on a 12-h light/
dark cycle (lights on at 07.00 h) and housed four to six per cage
before surgery and individually after surgery. Food and water were
always freely available. All experimental procedures were carried
out in strict accordance with European Communities Council
Directive on ‘Protection of Animals Used in Experimental and
Other Scientiﬁc Purposes’ of 24 November 1986 (86/609/EEC) and
were approved by the Institutional Animal Care and Use Commit-
tees. All efforts were made to minimize animal suffering and to
reduce the number of animals used.
Chemicals and drugs
All the reagents were of analytical grade and obtained from Merck
(Darmstadt, Germany). Fluoxetine hydrochloride, (R)-(+)-8-hydrox-
y-2-(di-n-propylamino)tetralin hydrobromide (8-OH-DPAT), 5-HT
oxalate, neutral red, fast green and formalin solution 10% neutral
buffered were purchased from Sigma (Saint Louis, MO, USA), and
1,4-dihydro-3-(1,2,3,6-tetrahydro-4-pyridinyl)-5H-pyrrolo[3,2-b]py-
ridin-5-one dihydrochloride (CP 93129) from Tocris (Bristol, UK).
Citalopram hydrobromide was generously donated by H. Lundbeck
A/S (Copenhagen-Valby, Denmark). Fluoxetine and 8-OH-DPAT
were dissolved in distilled water and saline, respectively, and
injected intraperitoneally (i.p.) in a volume of 2 mL/kg. CP 93129
was dissolved in artiﬁcial CSF. All doses and concentrations are
referred as free base. Groups of mice were perfused with artiﬁcial
CSF and injected with distilled water or saline to serve as control for
the systemic administration of drugs.
Dialysis procedures
Concentric dialysis probes were constructed as previously described
(Bortolozzi et al. 2003). Brieﬂy, the shaft of the probe was made up
of 15-mm long, 25 gauge (0.51 mm OD, 0.30 mm ID) stainless-
steel tubing (A-M Systems, Carlsborg, WA, USA). The inﬂow and
outﬂow tubes threaded through the 25 gauge tubing consisted of
fused silica capillary tubing of 0.11 mm OD and 0.04 mm ID
(Composite Metal Services Ltd, The Chase, Hallow, UK). The upper
exposed ends of silica tubings were inserted into 7-mm long, 27
gauge (0.41 mm OD, 0.20 mm ID) stainless-steel tubing. The
probes were secured to the skull with dental cement and two 2-mm
long, 0.95-mm diameter screws (Microbiotech/se AB, Stockholm,
Sweden). Mice were anesthetized with sodium pentobarbital
(40 mg/kg, i.p.) and mounted in a stereotaxic frame (David Kopf,
Tujunga, CA, USA). Each mouse was implanted with one dialysis
probe equipped with a Cuprophan membrane (1-mm long; 5000 Da
molecular weight cut-off) in the DR. Stereotaxic coordinates (in
mm) were AP )4.5, L )1.0, DV )4.4, with a lateral angle of 20,
from bregma and top of the skull according to Franklin and Paxinos
(1997). Microdialysis experiments were conducted 20–24 h after
surgery in freely moving mice by continuously perfusing probes
with artiﬁcial CSF containing 125 mM NaCl, 2.5 mM KCl, 1.26 mM
CaCl2 and 1.18 mM MgCl2. In some experiments, 1 lM citalopram
was added to the artiﬁcial CSF. When the effects of ﬂuoxetine on
5-HT efﬂux were examined, citalopram was omitted from the
perfusion ﬂuid to avoid confounding effects between both selective
serotonin reuptake inhibitors. The artiﬁcial CSF was perfused at a
rate of 1.5 lL/min with a WPI model sp220i syringe pump (WPI,
Aston, Stevenage, UK) attached to an overhead liquid swivel
(Instech, Plymouth Meeting, PA, USA). Dialysate samples of 30 lL
were collected every 20 min in microcentrifuge vials. After a
100-min stabilization period, four dialysate samples were collected
to obtain basal 5-HT values before pharmacological treatment
(8-OH-DPAT, CP 93129 or ﬂuoxetine) or behavioral manipulation
(saline injection or handling for 3 min). At the completion of
dialysis experiments, mice were given an overdose of sodium
pentobarbital and a fast green solution was perfused through the
dialysis probes to stain the surrounding tissue. Then the animals
were perfused transcardially with 0.9% saline followed by 10%
buffered formalin. Each brain was removed immediately, frozen at
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)70C and cut afterwards on a cryostat in the coronal plane at
50 lm. Each of the sections was then stained with neutral red,
according to standard procedures, for localization of the site of
perfusion.
Biochemical determinations
The concentration of 5-HT in dialysate samples was determined by a
HPLC method described previously (Adell and Artigas 1998). In
short, 5-HT was separated on a 3-lm octadecylsilica column
(7.5 cm · 0.46 cm; Beckman, San Ramon, CA, USA) and detected
amperometrically with a Hewlett-Packard 1049 detector (Palo Alto,
CA, USA) set at an oxidation potential of 0.6 V. The detection limit
for 5-HT was estimated to be around 1 fmol/sample. Quantiﬁcation
of 5-HT was carried out by an external standard method using a
Nelson Turbochrom Navigator (Perkin-Elmer, San Jose, CA, USA).
Data analysis
The content of 5-HT in each sample was expressed as percentage of
the average baseline level calculated from four fractions collected
before treatment. Data correspond to mean ± SEM values of the
percentage obtained in each experimental group. The changes in
dialysate 5-HT were analyzed by two-way repeated measures
analysis of variance (ANOVA). When signiﬁcant effects were found,
post-hoc comparisons were made with Tukey’s HSD multiple
comparison test. The regional differences in basal dialysate
concentrations of 5-HT between both strains were assessed by
Student’s t-test (two-tailed). The level of signiﬁcance was set at
p < 0.05. All statistical procedures were performed using the
Statistica software for Windows (StatSoft, Tulsa, OK, USA).
Results
Baseline 5-HT values
A representative site of a dialysis probe placement is shown
in Fig. 1. In the absence of citalopram in the perfusion ﬂuid,
the basal values of 5-HT in dialysate samples of the DR were
6.1 ± 0.8 fmol/30 lL (n ¼ 18) in 5-HT1A+/+ and 5.9 ± 0.5
fmol/30 lL (n ¼ 33) in 5-HT1A–/– mice. In the presence of
citalopram, the corresponding basal values were 46.4 ± 8.9
fmol/30 lL (n ¼ 17) in 5-HT1A+/+ and 54.7 ± 7.9 fmol/
30 lL (n ¼ 29) in 5-HT1A–/– mice. The inclusion of
citalopram in the perfusion ﬂuid elevated dialysate 5-HT in
the DR of wild-type and knockout mice to a comparable
extent (approximately eightfold). Both in the presence or
absence of citalopram in the artiﬁcial CSF, there was no
signiﬁcant difference in the basal 5-HT values between the
two lines of mice.
Effects of 8-OH-DPAT
This experiment was conducted in the presence of 1 lM
citalopram in the perfusion ﬂuid to allow comparison with
previous data. At this low concentration, local infusion of
citalopram does not result in substantial activation of
autoreceptors (Adell et al. 1993; Matos et al. 1996). As
depicted in Fig. 2 (upper panel), the systemic administration
of 0.5 mg/kg 8-OH-DPAT to 5-HT1A+/+ mice reduced DR
Fig. 1 Representative histological section cut in the coronal plane at
50 lm showing the tract of a dialysis probe located within the dorsal
raphe nucleus of the mouse. Scale bar, 1 mm.
Fig. 2 Effects of the injection (arrows) of saline (control) or 0.5 mg/kg
8-OH-DPAT on dialysate 5-HT in the DR of 5-HT1A+/+ mice (top pa-
nel) and 5-HT1A–/– mice (bottom panel). In 5-HT1A+/+ mice, a saline
injection (n ¼ 5) had no effect, whereas 8-OH-DPAT (n ¼ 5) signifi-
cantly decreased dialysate 5-HT (p < 0.0002). In 5-HT1A–/– mice, a
transient increase in dialysate 5-HT (p < 0.05, Tukey’s HSD test) was
observed following the injection of saline (n ¼ 8) or 8-OH-DPAT
(n ¼ 7).
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dialysate 5-HT to 30% of basal values (p < 0.0002), but this
effect was completely abolished in 5-HT1A receptor knock-
out mice (Fig. 2, lower panel). However, DR dialysate 5-HT
was increased in 5-HT1A–/– mice as a consequence of the
injection procedure, regardless of the solution injected (saline
or 8-OH-DPAT). This is shown by the signiﬁcant effect of
time (p < 0.001), but not of treatment (p ¼ 0.91) or the
interaction between both factors (p ¼ 0.07).
Effects of CP 93129
In this experiment, 1 lM citalopram was also added to the
perfusion ﬂuid to allow comparison with previous data on the
effects of CP 93129 on 5-HT efﬂux in the DR of rats (Adell
et al. 2001). The results are depicted in Fig. 3. ANOVA
revealed signiﬁcant effect of time (p < 0.00001), but not of
genotype (p ¼ 0.67) or the interaction between both factors
(p ¼ 0.15). Post-hoc comparisons showed that 100 lM CP
93129 was without effect. The effect of 300 lM CP 93129 in
reducing dialysate 5-HT was apparently more marked in
wild-type mice, but the difference between both genotypes
did not reach statistical signiﬁcance.
Effects of handling
In the present work, handling was deﬁned as picking a mouse
up and holding it tightly in the hand of the experimenter for
Fig. 3 Effects of the local perfusion of CP 93129 on dialysate 5-HT in
the DR of 5-HT1A+/+ mice (n ¼ 4) and 5-HT1A–/– mice (n ¼ 5). The
concentration of 100 lM CP 93129 failed to alter dialysate 5-HT, but
that of 300 lM reduced dialysate 5-HT to a comparable extent in both
genotypes (p < 0.05, Tukey’s HSD test).
Fig. 4 Effects of handling for 3 min (arrow) on dialysate 5-HT in the
DR of 5-HT1A+/+ and 5-HT1A–/– mice. In the absence of citalopram in
the perfusion fluid (upper panel), handling produced no effect in either
5-HT1A+/+ mice (n ¼ 4) or 5-HT1A–/– mice (n ¼ 5). In the presence of
1 lM citalopram in the perfusion fluid (lower panel), handling produced
no effect in 5-HT1A+/+ mice (n ¼ 5), but a significant increase in di-
alysate 5-HT (p < 0.05, Tukey’s HSD test) was observed at 20 and
40 min in 5-HT1A–/– mice (n ¼ 5).
Fig. 5 Effects of the injection (arrows) of vehicle (control) or fluoxetine
(FLX) on dialysate 5-HT in the DR of 5-HT1A+/+ mice (top panel) and
5-HT1A–/– mice (bottom panel). Vehicle injections had no effect in
5-HT1A+/+ mice (n ¼ 6) and 5-HT1A–/– mice (n ¼ 7). In contrast, flu-
oxetine at the doses of 5 mg/kg (n ¼ 4 for 5-HT1A+/+ mice and n ¼ 6
for 5-HT1A–/– mice) and 20 mg/kg (n ¼ 4 for 5-HT1A+/+ mice and
n ¼ 7 for 5-HT1A–/– mice) increased dialysate 5-HT in a dose-
dependent manner in both lines of mice. The effect of fluoxetine was
more prominent in 5-HT1A–/– mice, both at 5 mg/kg (p < 0.02) and
20 mg/kg (p < 0.005).
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3 min, and its effects on dialysate 5-HT are displayed in
Fig. 4. In the absence of citalopram in the perfusion ﬂuid
there was no effect of handling in either line of mice (Fig. 4,
upper panel). However, when 1 lM citalopram was added
(Fig. 4, lower panel), handling was without effect in
5-HT1A+/+ mice, but dialysate 5-HT increased twofold in
5-HT1A–/– mice, as shown by the signiﬁcant effects of
genotype (p < 0.05), time (p < 0.00002) and their interac-
tion (p < 0.01).
Effects of fluoxetine
The effects of systemic ﬂuoxetine on extracellular 5-HT in
wild-type and 5-HT1A receptor knockout mice are depicted
in Fig. 5. Two-way ANOVA showed that ﬂuoxetine increased
dialysate 5-HT in 5-HT1A+/+ mice in a dose-dependent
manner (Fig. 5, upper panel), as demonstrated by the
signiﬁcant effect of dose (p < 0.0001), time (p < 0.0001)
and the interaction between both factors (p < 0.001). Fluo-
xetine also elevated dialysate 5-HT in 5-HT1A–/– mice
(Fig. 5, lower panel), as shown by the signiﬁcant effect of
dose (p < 0.00005), time (p < 0.00001) and the interaction
between both factors (p < 0.00001). The effects of each dose
of ﬂuoxetine were greater in the 5-HT1A receptor knockout
mice in comparison with their wild-type counterparts. Thus,
the maximal effect of ﬂuoxetine on dialysate 5-HT in the DR
of 5-HT1A–/– mice, in comparison with 5-HT1A+/+ mice,
was 1.6-fold greater after the dose of 5 mg/kg (p < 0.02),
and 2.7-fold greater after the dose of 20 mg/kg (p < 0.005).
Discussion
The 5-HT1A receptor knockout mouse has been extensively
characterized in terms of its anxiety-like behavior in several
conﬂict tests (for review, see Toth 2003). However, little
work has been devoted to studying the in vivo efﬂux of 5-HT,
and so far this research has focused on forebrain regions. To
our knowledge, this is the ﬁrst report dealing with the in vivo
efﬂux of 5-HT in the DR of 5-HT1A receptor knockout mice.
The importance of the DR is further underscored by the fact
that it is particularly responsive, in terms of changes in 5-HT
efﬂux, to 5-HT1A receptor agonists (Casanovas et al. 1997)
and stressful conditions (Adell et al. 1997). In the present
work, the functional absence of 5-HT1A receptors in
5-HT1A–/– mice was veriﬁed by the failure of 8-OH-DPAT
to suppress the efﬂux of 5-HT. The disruption of the 5-HT1A
receptor gene did not induce changes in the basal extracel-
lular levels of 5-HT in the DR. This is coincident with
previous ﬁndings obtained in forebrain regions, both in vivo
(He et al. 2001; Knobelman et al. 2001b; Adell et al. 2003)
and in vitro (Ramboz et al. 1998; Richer et al. 2002). The
fact that 1 lM citalopram elevated dialysate 5-HT to a
comparable extent in both lines of mice suggests that the
efﬁciency of the 5-HT reuptake process, at least in the DR, is
not altered by the lack of the 5-HT1A receptors. This is in line
with previous work showing an absence of changes in the
density of 5-HT transporter in the raphe nuclei of 5-HT1A–/–
mice (Ase et al. 2001; He et al. 2001). However, the present
results do not seem to be in accordance with the increased
5-HT turnover seen in 5-HT1A–/– mice (Ase et al. 2000). It
is thus possible that the increased 5-HT turnover takes place
in the cytoplasmic compartment and does not alter the release
of the transmitter. The lack of changes in the basal efﬂux of
5-HT also agrees with an absence of major alterations in the
ﬁring rate of most DR serotonergic neurons (Richer et al.
2002; Adell et al. 2003), and provides further support to the
view that 5-HT1A autoreceptors are not tonically activated
under physiological conditions (Adell et al. 2002; Johnson
et al. 2002). In mice, the absence of a tonic control of
5-HT1A receptors upon serotonergic neurons has been
conﬁrmed by Mannoury la Cour et al. (2001), who showed
that the selective 5-HT1A receptor antagonist WAY 100635
did not affect the membrane potential of 5-HT cells in the
DR. Alternatively, it could be expected that adaptive changes
in the efﬁcacy of 5-HT1B receptors might have developed in
mice with a constitutive inactivation of the 5-HT1A receptor.
For instance, using the selective 5-HT1B receptor agonists CP
93129 or CP 94253, a compensatory enhanced responsive-
ness of 5-HT1B autoreceptors in 5-HT1A–/– mice has been
observed (Ramboz et al. 1998; Knobelman et al. 2001a;
Boutrel et al. 2002; but see Richer et al. 2002). However,
these adaptive changes have not been found with the 5-HT1B/
1D receptor agonist sumatriptan (Ramboz et al. 1998; Richer
et al. 2002), which suggests that the function of 5-HT1D
receptors is not changed in these mutant mice. In the present
study, the efﬁcacy of DR 5-HT1B receptors in reducing the
local efﬂux of 5-HT is not altered in 5-HT1A–/– mice, which
agrees with the lack of changes in the density of this receptor
in the DR (Ase et al. 2001) and argues against the
development of compensatory changes of 5-HT1B receptors
observed previously in mesencephalic slices (Ramboz et al.
1998). However, the occurrence of changes of the in vivo
function of 5-HT1D receptors in the DR of 5-HT1A receptor
knockout mice cannot be ruled out.
The existence of altered responses to different stressful
conditions in 5-HT1A–/– mice was also examined in the
present study. In the absence of citalopram in the artiﬁcial
CSF, both the injection of vehicle (control mice in ﬂuoxetine
experiments) and handling did not alter the basal efﬂux of
5-HT in either line of mice. In contrast, in the presence of
1 lM citalopram, the injection of vehicle, 8-OH-DPAT and
handling markedly enhanced the 5-HT output in 5-HT1A–/–,
but not in 5-HT1A+/+ mice. Recent research without the use
of citalopram has also provided conﬂicting results. Thus, a
saline injection did not alter striatal 5-HT output in both
genotypes (He et al. 2001) whereas an open ﬁeld exposure
enhanced cortical but not hippocampal 5-HT efﬂux in mice
lacking 5-HT1A receptors (Parsons et al. 2001). Therefore,
the effects of stress on the efﬂux of 5-HT depend on how the
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aversive stimulus is perceived, the brain region and the
sampling conditions. In the DR the density of 5-HT uptake
sites is very high (Hrdina et al. 1990; He et al. 2001) and
presumably sufﬁcient to dampen stress-related increases in
spillover of released 5-HT into extracellular space. Therefore,
it is likely that changes in the efﬂux of 5-HT would remain
latent unless the reuptake process is partly inhibited. In the
present study, the fact that 5-HT1A–/– mice exhibit an
enhanced response to stress indicates that 5-HT1A receptors
normally restrain the stress-induced enhancement of 5-HT
efﬂux in the DR, but this becomes apparent only under
conditions of decreased elimination of extracellular 5-HT. In
a previous study we observed that a saline injection and a
short handling elevated dialysate 5-HT in the raphe nuclei of
the rat (Adell et al. 1997). It thus seems that, with 5-HT1A
receptors intact, the DR of the rat is more responsive to the
effects of mild stressors than that of the mouse, although the
basis for this species difference are not fully understood.
The control of the extracellular concentration of 5-HT in the
DR of mice by 5-HT1A receptors was further studied by
investigating the effects of a challenge with the SSRI
ﬂuoxetine. In these experiments the use of citalopram was
avoided to prevent the effects of ﬂuoxetine frombeingmasked.
On the one hand, the systemic administration of ﬂuoxetine to
wild-type mice evoked increases in dialysate 5-HT lower than
those observed in theDR of the rat (Malagie´ et al. 1995; Rutter
et al. 1995; Herva´s and Artigas 1998), which may be
accounted for by species differences in the density of
5-HT1A receptors. On the other hand, the absence of 5-HT1A
receptors resulted in an enhanced ﬂuoxetine-induced response
of DR 5-HT in 5-HT1A–/– mice, consistent with the lack of
ﬂuoxetine-induced inhibition of 5-HT cell ﬁring in these mice
(Adell et al. 2003). Using mutant mice of different genetic
backgrounds, comparable results have also been obtained in
forebrain regions (He et al. 2001; Knobelman et al. 2001a,b;
Parsons et al. 2001). The enhanced response to systemic
ﬂuoxetine administration in the DR of 5-HT1A–/– mice
appears contradictory with the comparable increase in both
lines of mice after local citalopram administration (see above).
This discrepancy can be explained simply by the evidence that,
at 1 lM, citalopram only partially blocks the avid reuptake
process and this effect is limited to an area right next to the
probe. Thus, discharge and release of 5-HT may be virtually
unaltered. Additionally, 5-HT1A receptors in the forebrain also
control the efﬂux of 5-HT in the DR (Celada et al. 2001) and
the local perfusion of a SSRI into the DR would not inﬂuence
those receptors. In contrast, the increased responsiveness of
5-HT1A–/– mice to systemic ﬂuoxetine most likely reﬂects the
absence of the inhibitory mechanism(s) dependent upon
5-HT1A autoreceptors. As amatter of fact, the pharmacological
blockade of this inhibitory process mediated by 5-HT1A
autoreceptors augments the SSRI-induced increase in 5-HT
neurotransmission (Artigas et al. 1996; Romero and Artigas
1997). Thus, the potentiation of the effects of ﬂuoxetine in
mice constitutively deprived of 5-HT1A receptors provides
further support for the hypothesis that the absence of 5-HT1A
receptor-induced negative feedback increases the efﬁciency of
SSRIs (Artigas et al. 1994; Blier and Bergeron 1995; Perez
et al. 1997). Further research is needed to ascertain the
contribution of postsynaptic 5-HT1A receptors to the mechan-
ism of action of systemic SSRIs.
In conclusion, 5-HT efﬂux in the DR of 5-HT1A receptor
knockout mice was enhanced in response to stress and
ﬂuoxetine without apparent modiﬁcation of the function of
5-HT1B receptors.
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